Financhill
Back

Novo Nordisk AS Stock Predictions

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 20.6% based on the past 43 years of stock performance.
  • Novo Nordisk AS has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NVO] share price is $127.51. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 20.6% based on the past 43 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
39
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%

Novo Nordisk AS Stock Price History

Is NVO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
148.15
52-Week Low:
86.96

Prediction Charts

Market Cap:
567.6B
Price in USD:
127.51
Volume:
9.63M
Beta:
0.49

Technical Analysis

SMA50:
133.19
SMA100:
135.08
SMA200:
126.01
52-Wk Change:
34.6%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 127.51 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-3 138.56 136.26 138.62 135.83
Sep-4 134.04 134.53 134.91 133.63
Sep-5 132.01 130.89 132.66 130.53
Sep-6 133.76 131.14 134.16 130.57
Sep-9 132.03 131.91 132.94 130.91
Sep-10 129.23 129.78 130.12 128.40
Sep-11 133.14 135.23 135.82 130.98
Sep-12 135.24 136.66 136.97 134.65
Sep-13 136.86 137.00 137.89 136.37
Sep-16 138.06 136.90 138.22 136.77
Sep-17 133.60 132.00 135.16 131.80
Sep-18 132.83 132.06 133.27 131.30
Sep-19 134.66 134.88 135.20 133.63
Sep-20 129.10 127.51 129.48 126.13

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.91 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.